Vaginal Gel Helps Reduce HIV Transmission
A new topical gel that was announced at the International AIDS Conference in Vienna, Austria was said to help reduce the transmission of HIV to women.
A study shows that the gel, which contains the antiretroviral drug tenofovir, reduces infection chances up to 39%. For women who used it consistently, the reduction was at 54%.
The gel was used from 12 hours before to 12 hours after sexual intercourse. The study also found out that genital herpes was reduced by 51%.
The study involved 900 women from South Africa with ages ranging from 18 to 40.
The drug Tenofovir belongs to the reverse transcriptase inhibitors group of drugs. Such drugs slow down the growth of virus which means the slowing down of disease progression. It is is marketed by Gilead Sciences under the trade name Viread.
Women comprise around 16 million out of the 33 million people infected with the AIDS virus worldwide. In Africa alone, 60% of those infected are women. Major means of the transmission is via sexual intercourse.